CLINICAL_TRIALS
trial_result
· 2022-10-12
Clinical Trial Update: A Trial of AXS-05 in Patients With Major Depressive Disorder [Phase 3]
Summary
Phase 3 trial results for AXS-05 in major depressive disorder have been completed with results posted in 2022.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Axsome Therapeutics, Inc. | Conditions: Depression, Major Depressive Disorder | Phase 3 | Status: COMPLETED | Results posted: 2022-10-12